Study of the contraceptive action of a low dose oral progestagen (Exluton)
Bobtchev, T.
Bruxelles Medical 55(6): 337-342
1975
ISSN/ISBN: 0068-3027 PMID: 1222367 Document Number: 91406
Document emailed within 1 workday
Related Documents
Foley, M.; Law, B.; Davies, J.; Fotherby, K. 1973: Clinical trial and laboratory investigation of a low-dose progestogen-only contraceptive--Exluton International Journal of Fertility 18(4): 246-251Whyte, J.C.; Pooransingh, C.S. 1973: Low dosage progestagen as an oral contraceptive: a clinical study Canadian Medical Association Journal 109(4): 295-298
Iizuka, R.; Hayashi, M.; Kamouchi, Y.; Yamanaka, K. 1971: Evaluation of a low-dose progestagen as a contraceptive Nihon Funin Gakkai Zasshi 16(1): 68-82
Heinzl, S. 1989: Oral contraception with low-dose progestagen Medizinische Monatsschrift für Pharmazeuten 12(4): 123-124
Merz, M.; Kroll, R.; Lynen, R.; Bangerter, K. 2015: Bleeding pattern and cycle control of a low-dose transdermal contraceptive patch compared with a combined oral contraceptive: a randomized study Contraception 91(2): 113-120
Kuhnz, W.; al-Yacoub, G.; Fuhrmeister, A. 1992: Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation Contraception 46(5): 455-469
Koetsawang, S.; Srisupandit, S.; Srivanaboon, S.; Bhiraleus, P.; Rajawatana, D.; Kiriwat, O. 1975: Use of a low-dose oral contraceptive preparation: report of a study Modern Medicine of Asia 11(10): 8-11
Kamal, I.; Hefnawi, F.; Younis, N. 1970: Lynestrenol 1 mg.-mestranol 0.1 mg: a new low dose oral contraceptive: a clinical study Egyptian Population and Family Planning Review 3(1): 11-15
Kamal, I.; Hefnawi, F.; Younis, N. 1970: Lynestrenol 1 mg.-mestranol 0.1 mg: a new low dose oral contraceptive: a clinical study Egyptian Population and Family Planning Review 3(1): 11-15
Ziaei, S.; Rajaei, L.; Faghihzadeh, S.; Lamyian, M. 2002: Comparative study and evaluation of side effects of low-dose contraceptive pills administered by the oral and vaginal route Contraception 65(5): 329-331
Ziaei, S.; Rajaei, L.; Faghihzadeh, S.; Lamyian, M. 2002: Comparative study and evaluation of side effects of low-dose contraceptive pills administered by the oral and vaginal route Contraception 65(5): 329-331
O'Connell, K.J.; Osborne, L.M.; Westhoff, C. 2005: Measured and reported weight change for women using a vaginal contraceptive ring vs. a low-dose oral contraceptive Contraception 72(5): 323-327
Kallio, H.; Rhen, K. 1978: The contraceptive effects of a new low-dose combination type oral contraceptive Current Medical Research and Opinion 5(6): 444-449
Kallio, H.; Rhen, K. 1978: The contraceptive effects of a new low-dose combination type oral contraceptive Current Medical Research and Opinion 5(6): 444-449
Yang, Z.-J.; Ye, W.-S.; Cui, G.-H.; Guo, Y.; Xue, S.-P. 2004: Combined administration of low-dose gossypol acetic acid with desogestrel/mini-dose ethinylestradiol/testosterone undecanoate as an oral contraceptive for men Contraception 70(3): 203-211
Scholes, D.; Hubbard, R.A.; Ichikawa, L.E.; LaCroix, A.Z.; Spangler, L.; Beasley, J.M.; Reed, S.; Ott, S.M. 2011: Oral contraceptive use and bone density change in adolescent and young adult women: a prospective study of age, hormone dose, and discontinuation Journal of Clinical Endocrinology and Metabolism 96(9): E1380-E1387
Hofmann, B.; Reinecke, I.; Schuett, B.; Merz, M.; Zurth, C. 2014: Pharmacokinetic overview of ethinyl estradiol dose and bioavailability using two transdermal contraceptive systems and a standard combined oral contraceptive International Journal of Clinical Pharmacology and Therapeutics 52(12): 1059-1070
London, R.S.; Chapdelaine, A.; Upmalis, D.; Olson, W.; Smith, J. 1992: Comparative contraceptive efficacy and mechanism of action of the norgestimate-containing triphasic oral contraceptive Acta Obstetricia et Gynecologica Scandinavica. Suppl 156: 9-14
Samy Suissa; Brenda Hemmelgarn; Walter, O. Spitzer; James Brophy; Jean-Paul Collet; Robert Cǒte; Winanne Downey; Lindsay Edouard; Jacques Leclerc; Ora Paltiel 1993: The Saskatchewan oral contraceptive cohort study of oral contraceptive use and cardiovascular risks Pharmacoepidemiology and Drug Safety 2(1): 33-49
Surampudi, P.; Page, S.T.; Swerdloff, R.S.; Nya-Ngatchou, J.J.; Liu, P.Y.; Amory, J.K.; Leung, A.; Hull, L.; Blithe, D.L.; Woo, J.; Bremner, W.J.; Wang, C. 2014: Single, escalating dose pharmacokinetics, safety and food effects of a new oral androgen dimethandrolone undecanoate in man: a prototype oral male hormonal contraceptive Andrology 2(4): 579-587